期刊文献+

恶性肿瘤合并静脉血栓形成74例临床分析 被引量:4

Analysis of related factors of malignant tumor complicated with venous thromboembolism in 74 cases
原文传递
导出
摘要 目的:分析恶性肿瘤合并静脉血栓栓塞症(VTE)的相关因素,为恶性肿瘤合并VTE的早期预防及治疗提供临床依据。方法收集恶性肿瘤合并VTE患者74例,回顾性分析其临床资料。结果在74例肿瘤合并 VTE 患者中,男性多于女性,45~80岁50例(67.57%)。发生 VTE 最多的病种是肺癌27例(36.49%);既往有深静脉血栓栓塞、手术病史或者合并高血压的患者都易于发生 VTE,分别是14例(18.92%)、12例(16.22%)、11例(14.86%);57例(77.03%)VTE 患者曾行放疗和/或化疗;血小板计数、D-二聚体、纤维蛋白原、C反应蛋白(CRP)与肿瘤合并VTE 均有一定相关性。74例患者均接受了抗血栓治疗,其中67例(90.54%)主要通过药物抗凝治疗。结论肿瘤合并VTE 与患者的年龄、肿瘤病种、放/化疗史,既往病史以及凝血相关指标有关。了解肿瘤合并血栓的形成高危因素,有助于对VTE的预防、早期诊断与治疗,降低病死率。 Objective To discuss the related factors of the malignant tumor complicated with venous throm-boembolism(VTE),which may provide the clinical evidence for prevention,diagnosis and treatment of this disease. Methods Retrospectively reviewed the clinical data of patients with malignant tumor who were diagnosed with VTE from June 2012 to June 2015 in our hospital.Results Among 74 cases with tumor merger VTE,female with thrombosis was higher than the male.67.57% of the tumor with VTE patients was 45 -80 years old.Lung cancer patient with VTE was the highest almost 36.49%.Patients with deep vein catheterization,a history of surgery or merging of hyper-tension were easy occurred VTE,those were 14 cases (18.92%),12 cases (16.22%)and 11 cases (14.86%) respectively.57 VTE patients underwent radiotherapy or chemotherapy treatment.The platelet count,D -dimer, fibrinogen and CRP were associated with thrombosis.Among 74 cases with VTE,67 cases (90.54%)accepted anticoagulation therapy.Conclusion Sex,tumor disease,chemotherapy or radiotherapy treatment,medical history and coagluative function index were associated with VTE.Early diagnosis and treatment is the key to reduce mortality and improve prognosis of malignant tumor with VTE.
出处 《中国基层医药》 CAS 2017年第3期346-350,共5页 Chinese Journal of Primary Medicine and Pharmacy
基金 浙江省永康市科技计划项目(201351)
关键词 肿瘤 静脉血栓栓塞 放疗 化疗 实验室指标 抗凝治疗 Tumor Venous thromboembolism Radiotherapy Chemotherapy Laboratory indices Anticoagulation
  • 相关文献

参考文献8

二级参考文献91

  • 1Bick RL. Cancer-associated thrombosis[J]. N Eng J Med, 2003, 349(2): 109-111.
  • 2Letai A, Kuter DJ. Cancer, coagulation, and anticoagulation[J]. Oncologist, 1999, 4(6): 443--449.
  • 3Pruemer J. Prevalence, causes, and impact of cancer-associated thrombosis[]]. AmJ Health Syst Pharm, 2005, 62(22 Suppl 5): s4--s6.
  • 4Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using Medicare claims data[J]. Medicine, 1999, 78(5): 285-291.
  • 5Burris HA. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care[J]? Semin Oncol, 2006, 33(2 Suppl 4):S3-S16; quiz S41-S42.
  • 6BaronJA, Gridley G, Weiderpass E, et al. Venous thromboembolism and cancer[J]. Lancet, 1998, 351(9109): 1077-1080.
  • 7Sorensen HT, Mellemkjaer L, Steffensen FH, et al.. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism[J]. N EnglJ Med, 1998, 338 (17): 1169-1173.
  • 8GomuzJ, Pearson SD, Greager MA, et al. Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis[J]. Ann Intern Med, 1996, 125 (10): 785-793.
  • 9Murchison JT, Wyfie L, Stockton DL. Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study[]]. BrJ Cancer, 2004, 91(1): 92-95.
  • 10Monreal M, Lensing AW, Prins MH, et al. Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism[J].J Thromb Haemost, 2004, 2(6): 876-881.

共引文献306

同被引文献39

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部